Pioneer ACOs Reduce Utilization, Stem Spending Without Compromising Care, Study Finds

Email not displaying correctly?
View it in your browser.
G2 LogoLab and Pathology Insider Logo
 
May 12, 2015

Pioneer ACOs Reduce Utilization, Stem Spending Without Compromising Care, Study Finds

By Stephanie Murg, Managing Director, G2 Intelligence

The first wave of accountable care organizations (ACOs) is positioned well to achieve the touted goal of "bending the cost curve," according to a study published May 4 in the online edition of the Journal of the American Medical Association. When compared to general Medicare fee-for-service (FFS) beneficiaries, beneficiaries affiliated with Pioneer ACOs "exhibited smaller increases in total Medicare expenditures and…

Read more...


IBM's Watson to Speed Genomic Analysis, Personalized Cancer Care

By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies

Fourteen specialized cancer institutes will utilize IBM's Watson computing system to improve personalized oncology care, according to an announcement IBM made as part of the World of Watson symposium (Brooklyn, N.Y.; May 5-6). By applying Watson's advanced cognitive capabilities to genomic analysis, personalized treatment guidance can be recommended in minutes, rather than…

Read more...


New Platform Helps Labs Comply with Patient Access Requirements

By Kelly A. Briganti, Editorial Director, G2 Intelligence

Psyche Systems Corporation (Milford, MA), a laboratory information software company, and Luminate Health (San Francisco, CA), a provider of web-based services, have entered into a "strategic alliance" to provide a "first-of-its-kind platform that helps labs comply with new federal HHS legislation regarding patient access to lab results." Luminate contributes its HIPAA-compliant digital platform that connects…

Read more...


Invivoscribe, Astellas Enter Into Pact for Leukemia Testing

By Ron Shinkman, Editor, Laboratory Industry Report

Invivoscribe Technologies, a San Diego-based laboratory and equipment supplier, has entered into a companion testing pact with Astellas Pharma, Inc.

The deal will focus primarily on developing a diagnostic test focused on the FLT3 gene, which can be a biomarker for acute myeloid leukemia. Mutations in that particular gene can determine whether a patient will respond well to…

Read more...


Update: New Study Credits Criminal Attacks as Source of Most Healthcare Data Breaches

By Kelly A. Briganti, Editorial Director, G2 Intelligence

Last week, we referenced a 2014 study by Ponemon Institute that estimated the cost of a data breach to be around $200 per record in the United States, with the healthcare industry having one of the highest costs per record of all industries. After we went to press, the Ponemon Institute issued a new study this month indicating healthcare-related criminal attacks on data have increased 125 per cent since 2010 and are "the leading cause of data breach" in healthcare, while most organizations are still not prepared to respond to this latest threat to security of patient health information. "We are seeing a shift in…

Read more...

Follow on Twitter  Forward to Friend 

For questions concerning delivery of this email, please contact customer service at: (888) 729-2315 | customerservice@plainlanguagemedia.com

Copyright © 2015, All rights reserved.
Plain Language Media LLLP
PO Box 509
New London, CT
06320